Short interest in Enliven Therapeutics Inc (NASDAQ:ELVN) decreased during the last reporting period, falling from 8.22M to 6.05M. This put 14.52% of the company's publicly available shares short.

Based on the recent average volume of 2.12M shares traded per day, it would take 2.86 day(s) for holders of this short interest to close out their positions without sending the stock sharply higher.